The Cardano Foundation has urged EU policymakers not to introduce new regulations for decentralized finance (DeFi) and staking, advocating instead for improvements to the existing Markets in Crypto-Assets Regulation (MiCA). It emphasized the need to distinguish between direct blockchain participation and financial services run by intermediaries controlling customer assets. The Foundation also called for clearer rules on hybrid tokens, stablecoins, and NFTs, warning that inconsistent regulatory interpretations across EU countries could harm smaller crypto businesses. The European Commission is reviewing MiCA and considering whether additional oversight is needed for activities currently outside its scope, with the Foundation recommending regulatory clarity and consistency to support innovation and legal certainty in the crypto space.
The Cardano Foundation's call for EU regulatory clarity on DeFi and staking comes with this market context from Pluang. As of Oct 21, 2026 15:21 WIB, 43 of 50 major cryptocurrencies rose today. VeChain (VET) gained 7.19% to Rp130, Decentraland (MANA) rose 6.60% to Rp1.583, and COTI increased 6.19% to Rp208.
A webinar titled "Ready for AI?" scheduled for October 29, 2026, will discuss how artificial intelligence is reshaping public relations by changing how information is found, evaluated, and shared. Experts will share insights on maintaining message vi...
17a-4 LLC introduced DataParser Hub, an API that enables clients to integrate proprietary messaging and collaboration data into Microsoft 365 Purview and Copilot. This solution supports over 30 data types from platforms like Slack, Zoom, and Webex, a...
IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...
IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...
WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...
